Authors:
Lohmann, T
Kratzsch, J
Kellner, K
Witzigmann, H
Hauss, J
Paschke, R
Citation: T. Lohmann et al., Severe hypoglycemia due to insulin autoimmune syndrome with autoantibodiescrossreactive to proinsulin, EXP CL E D, 109(4), 2001, pp. 245-248
Authors:
Uhlmann, D
Witzigmann, H
Senninger, N
Hauss, J
Spiegel, HU
Citation: D. Uhlmann et al., Improvement of postischemic hepatic microhemodynamics by an endothelin converting enzyme inhibitor (FR 901533), TRANSPLAN P, 33(4), 2001, pp. 2549-2550
Authors:
Kohlhaw, K
Sack, U
Lehmann, I
Drews, G
Schwarz, R
Hartwig, T
Tannapfel, A
Berr, F
Oertel, M
Marx, U
Lehmann, M
Witterkind, C
Hauss, J
Emmrich, F
Citation: K. Kohlhaw et al., Anti-CD4-induced long-term acceptance of rat liver allografts in a high-responder model is not based on pure immunosuppression, TRANSPLAN P, 33(3), 2001, pp. 2173-2175
Authors:
Kohlhaw, K
Sack, U
Lehmann, I
Drews, G
Schwarz, R
Hartwig, T
Tannapfel, A
Berr, F
Oertel, M
Marx, U
Lehmann, M
Wittekind, C
Hauss, J
Emmrich, F
Citation: K. Kohlhaw et al., The monoclonal anti-CD4 antibody RIB5/2 induces donor-specific tolerance in the high-responder liver transplant model in the rat, TRANSPLAN P, 33(3), 2001, pp. 2371-2373
Authors:
Uhlmann, D
Witzigmann, H
Senninger, N
Hauss, J
Spiegel, HU
Citation: D. Uhlmann et al., Protective role of an endothelin-converting enzyme inhibitor (FR901533) inhepatic ischemia/reperfusion injury, MICROVASC R, 62(1), 2001, pp. 43-54
Authors:
Oertel, M
Berr, F
Schroder, S
Schwarz, R
Tannapfel, A
Wenzke, M
Lamesch, P
Hauss, J
Kohlhaw, K
Citation: M. Oertel et al., Acute rejection of hepatic allografts from HLA-DR13 (allele DRB11301)-positive donors, LIVER TRANS, 6(6), 2000, pp. 728-733
Authors:
Lohmann, T
List, C
Lamesch, P
Kohlhaw, K
Wenzke, M
Schwarz, C
Richter, O
Hauss, J
Seissler, J
Citation: T. Lohmann et al., Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/Tacrolimus, EXP CL E D, 108(5), 2000, pp. 347-352
Authors:
Berr, F
Wiedmann, M
Tannapfel, A
Halm, U
Kohlhaw, KR
Schmidt, F
Wittekind, C
Hauss, J
Mossner, J
Citation: F. Berr et al., Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival, HEPATOLOGY, 31(2), 2000, pp. 291-298
Authors:
Berr, F
Tannapfel, A
Lamesch, P
Pahernik, S
Wiedmann, M
Halm, U
Goetz, AE
Mossner, J
Hauss, J
Citation: F. Berr et al., Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma, J HEPATOL, 32(2), 2000, pp. 352-357
Authors:
Tannapfel, A
Weinans, L
Geissler, F
Schutz, A
Katalinic, A
Kockerling, F
Hauss, J
Wittekind, C
Citation: A. Tannapfel et al., Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver, DIG DIS SCI, 45(2), 2000, pp. 317-324
Authors:
Tannapfel, A
Grund, D
Katalinic, A
Uhlmann, D
Kockerling, F
Haugwitz, U
Wasner, M
Hauss, J
Engeland, K
Wittekind, C
Citation: A. Tannapfel et al., Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma, INT J CANC, 89(4), 2000, pp. 350-355
Authors:
Tannapfel, A
Benicke, M
Katalinic, A
Uhlmann, D
Kockerling, F
Hauss, J
Wittekind, C
Citation: A. Tannapfel et al., Frequency of p16(INK4A) alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver, GUT, 47(5), 2000, pp. 721-727
Authors:
Tannapfel, A
Wasner, M
Krause, K
Geissler, F
Katalinic, A
Hauss, J
Mossner, J
Engeland, K
Wittekind, C
Citation: A. Tannapfel et al., Expression of p73 and Its relation to histopathology and prognosis in hepatocellular carcinoma, J NAT CANC, 91(13), 1999, pp. 1154-1158